Srs Capital Advisors, Inc. Royalty Pharma PLC Transaction History
Srs Capital Advisors, Inc.
- $1.07 Billion
- Q3 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 576 shares of RPRX stock, worth $14,803. This represents 0.0% of its overall portfolio holdings.
Number of Shares
576
Previous 206
179.61%
Holding current value
$14,803
Previous $5,000
220.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
412Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.06 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$966 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$592 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$414 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$311 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...